Sitagliptin is one of many dipeptidyl peptidase-4 (DPP4) inhibitor groups of medications that have been used over many years to control type 2 diabetes mellitus (83) and approved by the FDA in 2006. Here, DPP4 is linked to diabetes mellitus.